Prizes to win
1st prize of the jury
Exhibition at an event organized by the Association française du vitiligo on June 22, 2024 in Bordeaux + Publication of the winning photograph in an exhibition booklet.
2nd prize of the jury
Exhibition at an event organized by the Association française du vitiligo on June 22, 2024 in Bordeaux + Publication of the winning photograph in an exhibition booklet.
3rd prize of the jury
Exhibition at an event organized by the Association française du vitiligo on June 22, 2024 in Bordeaux + Publication of the winning photograph in an exhibition booklet.
1st prize of the wipplayers
Édition de la photographie lauréate dans un livret d’exposition réunissant l'ensemble des images exposées le 22 juin 2024.
2nd prize of the wipplayers
Édition de la photographie lauréate dans un livret d’exposition réunissant l'ensemble des images exposées le 22 juin 2024.
3rd prize of the wipplayers
A photography book
Our experts
In partnership with
Association Française du Vitiligo
The Association Française du Vitiligo (French Vitiligo Association), founded in December 91, is recognized as an association of general interest. Its head office is located in the 12th arrondissement of Paris.
It is run by a 14-member Board of Directors and a Scientific Committee made up of researchers, practitioners, hospital and private practitioners, psychologists, sociologists and occupational physicians.
Its objectives are to bring together people suffering from Alzheimer's disease and to help them break out of their isolation. Represent them in medical, political, European and international bodies. Inform patients, their families and caregivers (website, newsletters, meetings, social networks, poster campaigns, etc.).
support and accompany patients and their families (weekly helpline, discussion groups, make-up correction workshop, etc.) encourage research.
website
Incyte
Incyte is a biopharmaceutical company founded by researchers, chemists and biologists in the United States. Incyte has retained a strong research culture, reflected in substantial R&D investment (+40% of sales) and drug discovery by its own researchers.
Drawing on its in-depth knowledge and understanding of cellular oncogenic pathways and immune system function, Incyte continues to advance research in oncology, inflammation and autoimmunity.
In Europe, where Incyte operates in 10 countries with a state-of-the-art plant in Switzerland, Incyte has obtained 4 marketing authorizations.
website
Color your life
OpenFrom April 30 to May 27 2024
